Regional differences in presentation of AIDS in Europe

被引:12
作者
Blaxhult, A [1 ]
Kirk, O
Pedersen, C
Dietrich, M
Barton, SE
Gatell, JM
Mulcahy, F
Hirschel, B
Mocroft, A
Lundgren, JD
机构
[1] Karolinska Hosp, Dept Infect Dis, S-17176 Stockholm, Sweden
[2] Hvidovre Univ Hosp, Copenhagen, Denmark
[3] Odense Univ Hosp, DK-5000 Odense, Denmark
[4] Bernhard Nocht Inst Trop Med, Hamburg, Germany
[5] St Stephens Clin, London, England
[6] Hosp Clin Barcelona, Barcelona, Spain
[7] St James Hosp, Dublin 8, Ireland
[8] Hosp Cantonal Univ, Geneva, Switzerland
[9] Royal Free Hosp, Ctr HIV Med, London NW3 2QG, England
关键词
D O I
10.1017/S0950268899004185
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Data were collected on 6578 patients diagnosed with AIDS at 52 clinical centres in 17 European countries during an Ii-year period from 1979 to 1989. The centres were divided into four regions, North, Central, Southeast, and Southwest. Differences in the incidence of most AIDS-defining opportunistic infections and malignancies were found. After adjusting for known possible confounders, statistically significant differences between regions remained. Pneumocystis carinii pneumonia (PCP) was more common in Northern Europe, Kaposi's sarcoma and toxoplasmosis in Central Europe, cytomegalovirus retinitis in South-eastern Europe, and extrapulmonary tuberculosis in South-western Europe. These differences we attribute primarily to different degrees of exposure to the respective underlying pathogens. The prevalence of these and other micro-organisms will determine the clinical course of HIV infections in parts of Eastern Europe and elsewhere where the virus now is spreading.
引用
收藏
页码:143 / 151
页数:9
相关论文
共 35 条
[1]  
[Anonymous], 1987, MMWR-MORBID MORTAL W
[2]   IMMUNE ACTIVATION IS A DOMINANT FACTOR IN THE PATHOGENESIS OF AFRICAN AIDS [J].
BENTWICH, Z ;
KALINKOVICH, A ;
WEISMAN, Z .
IMMUNOLOGY TODAY, 1995, 16 (04) :187-191
[3]   Kaposi's sarcoma in HIV infection:: impact on opportunistic infections and survival [J].
Brodt, HR ;
Kamps, BS ;
Helm, EB ;
Schöfer, H ;
Mitrou, P .
AIDS, 1998, 12 (12) :1475-1481
[4]  
CLUMECK N, 1989, OPPORTUNISTIC INFECT, P43
[5]   PERSISTENT DIARRHEA IN ZAIRIAN AIDS PATIENTS - AN ENDOSCOPIC AND HISTOLOGICAL STUDY [J].
COLEBUNDERS, R ;
LUSAKUMUNI, K ;
NELSON, AM ;
GIGASE, P ;
LEBUGHE, I ;
VANMARCK, E ;
KAPITA, B ;
FRANCIS, H ;
SALAUN, JJ ;
QUINN, TC ;
PIOT, P .
GUT, 1988, 29 (12) :1687-1691
[6]   Declining incidence and later occurrence of Kaposi's sarcoma among persons with AIDS in Australia: The Australian AIDS cohort [J].
Dore, GJ ;
Li, YM ;
Grulich, AE ;
Hoy, JF ;
Mallal, SA ;
Mijch, AM ;
French, MA ;
Cooper, DA ;
Kaldor, JM .
AIDS, 1996, 10 (12) :1401-1406
[7]   Geography of AIDS-associated Kaposi's sarcoma in Europe [J].
Ebrahim, SH ;
Peterman, TA ;
Zaidi, AA ;
Hamers, FF .
AIDS, 1997, 11 (14) :1739-1745
[8]   Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion [J].
Farzadegan, H ;
Henrard, DR ;
Kleeberger, CA ;
Schrager, L ;
Kirby, AJ ;
Saah, AJ ;
Rinaldo, CR ;
OGorman, M ;
Detels, R ;
Taylor, E ;
Phair, JP ;
Margolick, JB .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 13 (05) :448-455
[9]   Size and duration of zidovudine benefit in 1003 HIV-infected patients: US Army, Navy, and Air Force natural history data [J].
Gardner, LI ;
Harrison, SH ;
Hendrix, CW ;
Blatt, SP ;
Wagner, KF ;
Chung, RCY ;
Harris, RW ;
Cohn, DL ;
Burke, DS ;
Mayers, DL .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 17 (04) :345-353
[10]   Epidemiology of AIDS-related Kaposi's sarcoma in Europe over 10 years [J].
Hermans, P ;
Lundgren, J ;
Sommereijns, B ;
Pedersen, C ;
Vella, S ;
Katlama, C ;
Luthy, R ;
Pinching, AJ ;
Gerstoft, J ;
Pehrson, P ;
Clumeck, N .
AIDS, 1996, 10 (08) :911-917